341 related articles for article (PubMed ID: 12794364)
1. [Erythema nodosum association with malignant lymphoma].
Pileckyte M; Griniūte R
Medicina (Kaunas); 2003; 39(5):438-42. PubMed ID: 12794364
[TBL] [Abstract][Full Text] [Related]
2. Erythema nodosum and non-Hodgkin's lymphoma.
Thomson GT; Keystone EC; Sturgeon JF; Fornasier V
J Rheumatol; 1990 Mar; 17(3):383-5. PubMed ID: 2332863
[TBL] [Abstract][Full Text] [Related]
3. Erythema nodosum.
Requena L; Requena C
Dermatol Online J; 2002 Jun; 8(1):4. PubMed ID: 12165214
[TBL] [Abstract][Full Text] [Related]
4. Erythema nodosum and Hodgkin's disease.
Taillan B; Ferrari E; Fuzibet JG; Vinti H; Pesce A; Dujardin P
Clin Rheumatol; 1990 Sep; 9(3):397-8. PubMed ID: 2261740
[TBL] [Abstract][Full Text] [Related]
5. BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Palickova M; Mocikova H; Vernerova Z; Campr V; Kozak T
Leuk Lymphoma; 2013 Sep; 54(9):2081-2. PubMed ID: 23311295
[No Abstract] [Full Text] [Related]
6. More is not necessarily better when treating Hodgkin's lymphoma.
Connors JM
J Clin Oncol; 2011 Nov; 29(32):4215-6. PubMed ID: 21990411
[No Abstract] [Full Text] [Related]
7. Hodgkin's lymphoma--the great teacher.
Connors JM
N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
[No Abstract] [Full Text] [Related]
8. Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Bruessow C; Karrer U; Gubler J; Pless M
J Clin Oncol; 2012 Apr; 30(12):e130-2. PubMed ID: 22393099
[No Abstract] [Full Text] [Related]
9. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
10. Calcification in splenic lymphoma before chemotherapy.
Dai MS; Chao TY; Yu CY
South Med J; 2003 Aug; 96(8):836-7. PubMed ID: 14515933
[No Abstract] [Full Text] [Related]
11. [Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
Bernard P; Vinzio S; Talarmin F; Kadouri A; Flocard F
Rev Med Interne; 2003 Apr; 24(4):257-60. PubMed ID: 12706783
[TBL] [Abstract][Full Text] [Related]
12. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
13. [Erythema nodosum and cutaneous vasculitis revealing Hodgkin's disease. Apropos of 2 case reports].
Blanco P; Neau D; Pellegrin JL; Leng B
Rev Med Interne; 1999 Feb; 20(2):160-3. PubMed ID: 10227095
[TBL] [Abstract][Full Text] [Related]
14. PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
Deau B; Franchi P; Briere J; Ohnona J; Tamburini J; Thieblemont C; Brice P
Br J Haematol; 2015 Jul; 170(2):278-81. PubMed ID: 25580881
[No Abstract] [Full Text] [Related]
15. Erythema elevatum diutinum with rare distribution as a first clinical sign of non-Hodgkin's lymphoma: a novel association?
Hatzitolios A; Tzellos TG; Savopoulos C; Tzalokostas V; Kaiafa G; Psomas E; Apostolopoulou M; Papadopoulos A
J Dermatol; 2008 May; 35(5):297-300. PubMed ID: 18477231
[TBL] [Abstract][Full Text] [Related]
16. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphomas.
Theodossiou C; Schwarzenberger P
Clin Obstet Gynecol; 2002 Sep; 45(3):820-9. PubMed ID: 12370624
[No Abstract] [Full Text] [Related]
18. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
19. Complete regression of cardiac non-Hodgkin lymphoma.
Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
[No Abstract] [Full Text] [Related]
20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
